Navigation Links
Jennerex Therapeutic Research Collaboration With Ottawa Hospital Research Institute Selected for $10 Million Grant From Ontario Institute for Cancer Research
Date:6/11/2009

SAN FRANCISCO, June 11 /PRNewswire/ -- Jennerex, Inc. (San Francisco, CA and Ottawa, Canada), a clinical-stage biopharmaceutical company, announced today that a $10 million grant from the Ontario Institute for Cancer Research (OICR) has been received by the Centre for Cancer Therapeutics at Ottawa Hospital Research Institute (OHRI). A large portion of this grant will fund research and development in the lab of Dr. John Bell, Jennerex's chief collaborator for the discovery and development of oncolytic viral therapeutics for cancer patients. Funding will support the translation of discoveries into medical products with the potential to prolong the lives of cancer patients. The grant, which provides $10 million (CAD) over four years, will fund the research and development of novel therapeutics including the development of Jennerex's oncolytic viral therapy products. Jennerex products have shown tumor destruction and safety in Phase 1 and 2 clinical trials.

"We are very pleased that Dr. Bell and Jennerex's oncolytic virus technologies have been given this vote of confidence by the Ontario Institute for Cancer Research. This funding will bolster the translation of Dr. Bell's promising research into important cancer therapeutics," stated David H. Kirn, M.D., president and chief executive officer of Jennerex. "We believe that there is significant potential in Ontario for medical innovation and development, and we value our partnerships in Ontario a great deal."

"This collaboration has been a great example of academia and industry working together to translate biological research into cutting edge therapies quickly and effectively," said Dr. John Bell, Senior Scientist at the Ottawa Hospital Research Institute and Professor of Medicine at the University of Ottawa.

Jennerex is conducting Phase 2 clinical trials for several types of cancer in Ontario, Canada. In addition, the company has a strong and co
'/>"/>

SOURCE Jennerex, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Jennerex Presents Clinical Data From JX-594 Demonstrating Tumor Efficacy Against Advanced Liver Cancers
2. Jennerex Publishes Promising Results from Cancer Clinical Trial of JX-594 in Lancet Oncology
3. Jennerex Publishes Clinical Trial Data With Lead Product JX-594 Demonstrating Efficacy Against Liver Cancer and Associated Hepatitis B Virus
4. Jennerex Completes the Treatment of First Patient Cohort in Phase 1 Trial With Intravenous Delivery of JX-594 Oncolytic Virus
5. Jennerex Treats First Patients in Phase 2 JX-594 Trial for Liver Cancer
6. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
7. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. TorreyPines Therapeutics Completes Patient Enrollment in Phase IIb Clinical Trial of Tezampanel for the Treatment of Acute Migraine Headache
10. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
11. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... 19, 2014 Research ... the addition of the "Global Gynecological ... offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... classified into wide categories based on their ... treatment of different gynecological conditions that affect ...
(Date:9/19/2014)... CHICAGO , Sept. 19, 2014  4WEB Medical ... of 3D-printed foot and ankle osteotomy implants on ... and Ankle Society annual meeting in Chicago ... for all of a surgeon,s osteotomy needs with 74 size ... wedge systems had smaller offerings of only 15 to 18 ...
(Date:9/19/2014)... , Sept. 19, 2014 UBM Medica US ... leading online community to help oncologists and other clinicians ... regarding the use of targeted therapies and immunotherapies, discusses ... and treatment.  Every September, Blood ... to raise awareness about blood cancers—helping to increase survival ...
Breaking Medicine Technology:Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 2Global Gynecological Devices Market 2014-2018: Key Vendors are Bayer, Boston Scientific, CooperSurgical, Ethicon, Hologic, Medtronic, Olympus and Stryker 34WEB Medical Unveils 3D-Printed Osteotomy Truss System 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4
... Journal of Medicine Study Questions Value of Knee ... new study,questioning the usefulness of arthroscopic surgery for ... physical therapy as an,effective non-surgical option, according to ... published in the September 11 issue of,the New ...
... Vanda,Pharmaceuticals Inc. (Nasdaq: VNDA ), a biopharmaceutical ... product candidates,for central nervous system disorders, reported today ... 2008 and discuss the iloperidone non-approvable action,letter that ... Vanda presented arguments to support its belief that ...
Cached Medicine Technology:New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 2New Research Shows Physical Therapy as Effective as Arthroscopic Knee Surgery 3Vanda Pharmaceuticals Provides Update on Iloperidone 2Vanda Pharmaceuticals Provides Update on Iloperidone 3
(Date:9/21/2014)... (PRWEB) September 21, 2014 The Laboratory ... businesses and manufacturers perform tests on items ranging from ... increasingly regulated society, pressure on operators to ensure the ... ever. A greater number of government safety regulations and ... goods prior to sale. Although revenue briefly dipped in ...
(Date:9/21/2014)... why cancer cells metastasize? Think of Sparta. , Ancient ... prepared them for the demands of battle on distant ... thing according to a new study revealing previously unknown ... the original tumor site, and those that travel to ... ability to metastasize is the primary cause of cancer-related ...
(Date:9/21/2014)... 21, 2014 (HealthDay News) -- Young women starting college ... which foods they should eat. But they aren,t confident ... according to a new study. The study ... of Illinois,s Peer Education Exercising and Eating Right program. ... they choose to eat if they were very busy ...
(Date:9/21/2014)... 2014 To accommodate the ever-growing customer ... provide more trendy items. Recently, the company has unveiled ... the new and elegant wedding gowns, Angeldress.co.uk wants to ... need in an easy way. Its high quality vintage ... from 12% off to 62% off. , Online shopping ...
(Date:9/21/2014)... Recently, BambooIndustry.com, an experienced producer of natural ... bamboo panels ( http://www.bambooindustry.com/products/bamboo-panel/ ). The company’s excellent panels ... are available at discounted prices now, from 10 to ... bamboo panels are available in many specifications; they ... of them is finely manufactured by qualified workers. They ...
Breaking Medicine News(10 mins):Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Laboratory Testing Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3Health News:Cancer cells adapt energy needs to spread illness to other organs 2Health News: College Women Can Use Food Strategies, Study Finds 2Health News:Angeldress.co.uk Launches New Range Of 2014 Vintage Wedding Dresses In Its Online Store 2Health News:Discounted Bamboo Panels For Sale At BambooIndustry.com 2
... Finding is good news for first-line treatment in Africa, researchers ... finding that has implications for how the AIDS virus is ... be given without routine monitoring by lab tests. , But ... to monitor the progression of the disease and guide the ...
... , , BERKELEY, Calif., Dec. 9 NeuroFocus, ... two more members to its Advisory Board. , The Advisory ... business and provides NeuroFocus and its clients, many of whom ... , Dr. Hans-Jochen Heinze , Dr. ...
... , , , ARLINGTON, Va., Dec. ... Officer of the Healthcare Distribution Management Association (HDMA), issued ... to the Patient Protection and Affordable Care Act, which ... "Importation of prescription drugs from foreign countries, as Senator ...
... ... been more compatible…now The Paper Tiger Document Management and Filing System Software is compatible ... ... document management and paper filing system software product is now compatible with ...
... ... of software & technology to Home Medical Equipment, Durable Medical Equipment & Home Healthcare ... (Vocus) ... fully automates the financial, clinical and operational aspects of a Home Medical Equipment and ...
... Dimes Polls Moms On Their Fears; Doctors Discuss Their Top Concerns ... moms. From the minute they start thinking about whether they want to have ... baby be healthy? Will I be a good mom? Can I dye my ... polled about 1,200 moms to find out exactly what it is that caused ...
Cached Medicine News:Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 2Health News:NeuroFocus Adds Two More of the World's Leading Neuroscientists to its Advisory Board 3Health News:Statement of HDMA President and CEO John M. Gray on the Importation of Prescription Drugs 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 2Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 3Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 4Health News:The Paper Tiger Document Management and Filing System Software Announces "Windows 7 Compatibility" 5Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 2Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 3Health News:Fastrack Announces Enhancements to the Enterprise System for HME/Respiratory Providers 4Health News:Sushi & Breastfeeding Join Birth Defects & Preterm Birth as Leading Concerns of Moms 2
Double ended with 0.5mm x 10mm and 1.0mm x 15mm blades; both blades gently curved; round serrated handle, In Titanium....
0.6mm Tip x10mm Shaft, Straight Shaft, 90 Degree Hook at Tip; overall length 120mm; in Titianium....
... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
Medicine Products: